Risk-based Monitoring - Risk-optimized approaches to clinical trials - Part 3 of 3

Поделиться
HTML-код
  • Опубликовано: 24 янв 2025

Комментарии • 2

  • @okola23
    @okola23 11 месяцев назад

    How is the determination of high, intermediate and low processes/data points made? I am used to categorize datapoints as critical and non-critical, which I now realize is a limited approach. Critical data points are those linked to study endpoints (primary, secondary and even tertiary). Critical processes are the processes that allow the capture of critical data points.

  • @eMJeyCGN
    @eMJeyCGN 2 года назад

    The colour-coded SoE can be used during planning at start up but I don't think it's an effective tool during conduct. It's a proxy at best, at worst it's going to confuse CRAs who are used to looking at EDC for outstanding SDV.